Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,951 public trials 2,018 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients

NCT07663253

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Shenzhen People's Hospital Shenzhen, Guangdong, China
  • The First Affiliated Hospital of Guangxi Medical University Naning, Guangxi, China
View all 13 locations
View Trial Details
Recruiting

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

NCT05850234

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
View all 36 locations
View Trial Details
Recruiting

Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia

NCT06648889

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • University Hospital Augsburg, II. Medizinischen Klinik, Hämatologie, internistische Onkologie und Hämostaseologie Augsburg, Germany
  • Charité Berlin, Campus Benjamin Franklin, Department of Hematology, Oncology and Tumorimmunologyt Hämatologie Berlin, Germany
  • Gesundheit Nord Klinikverbund Bremen gGmbH, Klinikum Bremen-Mitte, Med. Klinik I Bremen, Germany
  • Klinikum Carl Gustav Carus Dresden, Medizinische Klinik und Poliklinik I Dresden, Germany
View all 15 locations
View Trial Details

Related conditions